“No genetic toxicology studies have been conducted with teplizumab or the surrogate.”
✓ VerifiedFDA pharmacology/toxicology review, p. 34Source ↗
Carcinogenicity
Not conducted (short treatment, no rodent activity, anaphylaxis with surrogate); weight-of-evidence assessment
“The short duration of treatment, the absence of pharmacologic activity in the rodent (for teplizumab itself), and the observations of anaphylaxis and hypersensitivity following various dosing regimens in the rodent limit the utility of carcinogenic assessments”
✓ VerifiedFDA pharmacology/toxicology review, p. 34Source ↗
Reproductive & developmental
Mouse surrogate: no fertility effects; EFD post-implantation loss at 20 mg/kg (NOAEL 0.3); PPND: impaired offspring immune response and F1 fertility
“In an embryofetal development study there was an increased incidence of post-implantation loss at the HD of 20 mg/kg that included the loss of the entire litter for multiple females leading to identifications of the MD (0.3 mg/kg) as the NOAEL.”
✓ VerifiedFDA pharmacology/toxicology review, p. 8Source ↗
Safety pharmacology
Incorporated into single-dose chimpanzee study; no effects on temperature, ECG, heart rate, blood pressure or respiration
“No treatment-related effects on safety pharmacology endpoints, including body temperature, ECGs, heart rate, blood pressure, or respiratory rate were seen.”